TeleCareSpot Tirzepatide Review: Monthly Price & Refund Limits
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
A monthly tirzepatide plan with a separate consultation and refund limits.
Standout details
- Publishes named monthly tirzepatide and separate consultation amounts
- Describes evaluation, prescribed monthly supply and ongoing support
Things to consider
- Nonapproval refunds exclude the consultation fee
- Cancellation after pharmacy processing is nonrefundable; medication that leaves pharmacy cannot be returned
TeleCareSpot’s named tirzepatide page lists a program from $399 per month. A separate weight-loss page advertises a $79 one-time, 20-minute consultation, whose fee may be credited toward an eligible treatment program. The credit is not presented as automatic for every patient or plan.3,4
Confirm the program and any consultation charge
The tirzepatide FAQ says the monthly program includes evaluation, provider review, prescription management, all prescribed dose levels, a monthly supply if prescribed, delivery and ongoing support. Other wording qualifies delivery by availability and inclusion. Ask whether the selected quote includes the consultation, shipping, required laboratory work and any extra assessment.3,4
The provider may request additional medical details, laboratory results or a consultation before deciding on treatment. Completing an evaluation or paying for a visit does not guarantee a prescription. A “from” price is not a personal prescription quote or confirmation of the supplied preparation and quantity.3,4
Price comparison
| Item | Published detail |
|---|---|
| Tirzepatide program | From $399/month; monthly supply if prescribed |
| Separate consultation | $79 one-time for 20 minutes |
| Fee credit | May apply toward an eligible program; not universal |
| Other charges | Confirm labs, additional assessment and delivery for selected plan |
Refunds can stop at pharmacy processing
The general FAQ says patients who are not approved receive a refund minus the consultation fee. It also says prescription medications that leave the pharmacy cannot be returned or refunded, and cancellation requests received after the pharmacy processes the order are not refundable. That processing cutoff can precede delivery and matters even when cancellation is advertised as available anytime.5
The WeightCare review describes an earlier refund boundary: its policy offers a full refund on a cancellation request made before the medical questionnaire is submitted, while refunds after submission are generally unavailable. It separately preserves a full-refund promise if the assigned physician finds the patient ineligible. Confirm the applicable stage and exception before assuming a refund window lasts until pharmacy processing or shipment.8
The homepage and FAQ describe flexible subscriptions without long-term commitments, but do not establish a universal advance-notice deadline for stopping the next charge or an automatic credit of the $79 visit fee. Obtain the recurring billing date, cancellation instructions and refund scope for the selected plan.4,5,6
The terms page, dated September 9, 2025, labels its refund section as a sample that should be adjusted. It mentions a seven-day refund request and twelve-hour cancellation window, but does not reliably explain how those generic statements apply to prescription care. Request the actual medication and consultation agreement rather than relying on those windows as confirmed prescription refund rights.7
Cancellation and refunds
| Item | Published detail |
|---|---|
| Not approved | FAQ: refund minus consultation fee |
| Pharmacy processing | No refund for cancellation requested after order processing |
| Medication returns | No returns/refunds after medication leaves pharmacy |
| Published terms | Refund section labeled sample; obtain actual medication agreement |
Confirm the care and dispensing arrangements
TeleCareSpot describes provider evaluation, prescription management and follow-up, but a public program description does not establish your assigned clinician, current credentials or actual preparing/dispensing pharmacy. Ask whether the offered prescription is branded or compounded, its formulation and supplied quantity, and who manages questions or adverse effects.3,4
The homepage also markets an oral tirzepatide option and DNA-based personalization. Those descriptions do not establish that the oral preparation has the same evidence as injected brand medication, that a DNA test is required for your plan or that it is included in the quoted price. Clarify testing, formulation and any additional cost before comparing offers.6
The footer excludes Alaska, Mississippi and New Jersey. Confirm current availability where you are located and accept only a plan whose full charges and cancellation/refund agreement you understand. The page’s clinical review and service claims do not establish personal eligibility.3,6
Brand-drug trials do not establish outcomes for this platform or its compounded preparations. SURMOUNT-1 and SURMOUNT-5 provide clinical context, not verification of the platform’s testimonials or personalization claims.1,2
Further reading
whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, TeleClinic, Ondra Health, best tirzepatide providers.
Frequently asked questions
Does the $399 monthly price include the $79 consultation?
The named tirzepatide plan starts at $399/month. A separate page advertises a $79, 20-minute consultation that may be credited toward an eligible program. Confirm whether it is needed, credited and included in your selected total, along with labs and delivery.
What happens if I am not approved or want to cancel?
The FAQ says nonapproval refunds exclude the consultation fee. It also bars refunds for cancellation requests received after pharmacy processing and for medication that has left the pharmacy. Cancel-anytime marketing does not guarantee a refund of completed or processing services.
Can I rely on the terms’ seven-day refund or twelve-hour cancellation window?
The September 2025 terms label that section as a sample requiring adjustment. Obtain the actual prescription, consultation and recurring-payment agreement; the general sample windows do not establish confirmed medication refund rights.
References(8)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- TeleCareSpot (2026). Named tirzepatide monthly program and inclusions. TeleCareSpot.
- TeleCareSpot (2026). Weight-loss programs: $79 consultation and possible credit. TeleCareSpot.
- TeleCareSpot (2026). FAQ: consultation-fee deduction and pharmacy-processing refund cutoff. TeleCareSpot.
- TeleCareSpot (2026). Homepage: subscription, oral option and state exclusions. TeleCareSpot.
- TeleCareSpot (2025). Terms and conditions, last updated September 9, 2025. TeleCareSpot.
- WeightCare (2026). Refund policy. WeightCare.
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsWeightCare Tirzepatide Review: Supply Plans, Renewals & Refunds
Compare WeightCare’s monthly and longer-supply tirzepatide prices with renewal amounts, questionnaire-stage refund limits and partial-shipment rules.
ReadTeleClinic Tirzepatide Review: Intro Plans & Refund Stages
TeleClinic’s one- and three-month introductory offers, price-lock wording and separate medication and consultation refund rules.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
Read